CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
Progesteronedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00377923
NCT00377923Phase 1Completed
CompareCT.gov

Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers

IBSA Institut Biochimique SA·interventional·Posted Sep 19, 2006·Updated Sep 20, 2006

In Brief

A Phase 1 clinical trial evaluating Progesterone for Healthy. Completed.

Detailed Summary

This is a multiple dose, observer blind, randomised, parallel groups pharmacodynamic and pharmacokinetic study to assess the endometrial effects (predecidual changes) of a new aqueous progesterone formulation administered s.c. at the dose of 25 and 50 mg/day.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 19, 2006
Enrollment StartAug 1, 2005
Study CompletionMar 1, 2006
TodayJul 2, 2026
Posted 19.8 years ago

Interventions

Progesteronedrug